干扰素α中和抗体可区分成人隐匿性自身免疫糖尿病与早发1型糖尿病
研究比较了41例成人隐匿性自身免疫糖尿病(LADA)与90例早发1型糖尿病(T1D)患者中针对干扰素α(IFN-α)自身抗体的阳性率。LADA组针对≥2种和3种IFN-α亚型的自身抗体阳性率分别为17.1%和12.2%,T1D组分别为3.3%和0(P=.011和P=.0025)。LADA阳性者中IFN-α2亚型抗体水平与谷氨酸脱羧酶抗体水平呈负相关(rho=-0.513;P=.025)。
要点
- LADA组针对≥2种IFN-α亚型的自身抗体阳性率为17.1%,T1D组为3.3%(P=.011)。
- LADA组针对3种IFN-α亚型的自身抗体阳性率为12.2%,T1D组为0(P=.0025)。
- LADA阳性者IFN-α2抗体水平与谷氨酸脱羧酶抗体水平呈负相关(rho=-0.513;P=.025)。
核心结论
- 针对IFN-α的自身免疫是自身免疫糖尿病所特有的,并且似乎区别于其缓慢进展型。
- 理解这一新型自身免疫的分子机制和临床意义可能有助于开发自身免疫疾病的新治疗策略,推进个体化医疗。
研究设计与样本
- 采用基于细胞的方法检测41例LADA和90例T1D受试者血清中针对IFN-α亚型的自身抗体水平。
- 主要结局为LADA与T1D之间针对≥2种IFN-α亚型自身抗体阳性比例的差异,次要结局为针对3种IFN-α亚型自身抗体阳性比例的差异。
- 分析了LADA受试者中IFN-α自身抗体的存在及水平与临床和生化特征的关系。
主要发现
- LADA组7例(17.1%)和5例(12.2%)分别对≥2种和3种IFN-α亚型自身抗体阳性,T1D组3例(3.3%)和0例阳性(P=.011和P=.0025)。
- 在LADA中,对≥2种IFN-α亚型自身抗体阳性的个体空腹血糖和糖化血红蛋白水平在数值上低于阴性或仅对1种IFN-α亚型自身抗体阳性的个体。
- 在LADA阳性个体中,IFN-α2亚型自身抗体水平与谷氨酸脱羧酶抗体水平呈负相关(rho=-0.513;P=.025)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Autoantibodies against interferon-α (AAb-IFN-α) might be associated with the less aggressive autoimmunity in latent autoimmune diabetes in adults (LADA) compared to early-onset type 1 diabetes (T1D). OBJECTIVE: To investigate the presence and clinical relevance of the positivity to AAb-IFN-α in people with LADA compared to T1D. RESEARCH DESIGN AND METHODS: Serum levels of AAb-IFN-α isoforms were measured using a cell-based approach in 41 subjects with LADA and 90 subjects with T1D. OUTCOMES: The primary and secondary outcomes were the difference between LADA and T1D in the proportion of participants testing positive for autoantibodies (AAb) against ≥2 and against 3 interferon-α (IFN-α) isoforms, respectively. The presence and levels of AAb-IFN-α were related to clinical and biochemical features of participants with LADA. RESULTS: Seven (17.1%) and 5 (12.2%) participants with LADA and 3 (3.3%) and 0 participants with T1D showed positivity for AAb against ≥2 and 3 IFN-α isoforms (P = .011 and P = .0025, respectively). Fasting blood glucose and hemoglobin A1c levels were numerically lower among people with LADA testing positive for AAb against ≥2 IFN-α isoforms than among those who were either negative or positive for AAb against 1 IFN-α isoform. Among LADA-positive individuals, levels of AAb-IFN-α2 isoform were inversely correlated with glutamic acid decarboxylase antibodies levels (rho = -0.513; P = .025). CONCLUSION: Autoimmunity against IFN-α is peculiar to autoimmune diabetes and appears to be distinctive to its slowly progressive forms. Understanding the underlying molecular mechanisms and clinical significance of this novel autoimmunity could lead to the development of new therapeutic strategies in autoimmune diseases, advancing personalized medicine.
引用
- Amendolara R, D'Onofrio L, Sessa RL, et al. IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 39760686. doi:10.1210/clinem/dgaf001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。